Nippon India Pharma Fund Direct IDCW
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct IDCW
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8365.4
Nippon India Pharma Fund Direct IDCW - Nav Details
Nav Date
: 14-May-2026
NAV [Rs.]
: 166.6385
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct IDCW- NAV Chart
Nippon India Pharma Fund Direct IDCW- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 1.19 | 9.3 | 8.22 | 4.98 | 10.89 | 25.07 | 14.66 | 18.09 |
| Category Avg | 1.02 | 9.74 | 9.84 | 5.23 | 12.03 | 25.44 | 14.81 | 15.34 |
| Category Best | 2.1 | 12.01 | 12.79 | 10.48 | 21.62 | 29.56 | 17.39 | 30.12 |
| Category Worst | -2.76 | 5.28 | 3.1 | -1.72 | 3.42 | 21.5 | 11.3 | -0.85 |
Nippon India Pharma Fund Direct IDCW- Latest Dividends
Record DateDividend %Bonus
03-Feb-20261200
Nippon India Pharma Fund Direct IDCW- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
J B Chemicals &7,99,649
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 13.85 | 6406349 | 1,158.46 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 7.95 | 2883991 | 664.81 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 7.04 | 4449746 | 588.65 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 6.61 | 850754 | 553.20 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 5.47 | 3495054 | 457.71 |
| Equity | Apollo Hospitals | Healthcare Services | 5.01 | 548795 | 419.08 |
| Equity | Medplus Health | Retailing | 3.78 | 3627277 | 316.35 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.36 | 2486684 | 280.89 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 3.27 | 2555745 | 273.32 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.19 | 946323 | 267.11 |
| Equity | Max Healthcare | Healthcare Services | 3.16 | 2658082 | 263.96 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.04 | 1131195 | 254.14 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.83 | 1702630 | 236.58 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 2.55 | 913226 | 213.36 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.50 | 1364742 | 208.92 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.26 | 74187 | 188.69 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.11 | 4400180 | 176.13 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.09 | 323678 | 174.78 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 1.99 | 1218224 | 166.55 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.79 | 318249 | 149.91 |
| Equity | Narayana Hrudaya | Healthcare Services | 1.74 | 823911 | 145.55 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.68 | 800549 | 140.16 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.50 | 746337 | 125.39 |
| Equity | Syngene Intl. | Healthcare Services | 1.43 | 2560974 | 119.76 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.32 | 3896349 | 110.63 |
| Equity | Fortis Health. | Healthcare Services | 1.22 | 1103889 | 101.88 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.22 | 213659 | 101.78 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.99 | 1515264 | 82.93 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.96 | 1058503 | 80.45 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 0.93 | 230272 | 78.45 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 0.63 | 1469374 | 52.84 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.61 | 62568 | 51.38 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.46 | 1834924 | 38.43 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.15 | 111738 | 12.76 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,40,030.99
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
